January 30, 2015 10:19 AM ET

Healthcare Equipment and Supplies

Company Overview of Nanospectra Biosciences, Inc.

Company Overview

Nanospectra Biosciences, Inc., a medical device company, engages in the development and commercialization of particle-based therapy devices for the selective and precise particle-based thermal destruction of solid tumors. It develops AuroLase therapy, an investigational medical device that is used to ablate irregularly shaped tumors or inoperable solid tumors in refractory or recurrent head and neck cancer treatments. The company also develops and sells research-use-only nanoparticles with specific optical characteristics. Nanospectra Biosciences, Inc. was founded in 2002 and is based in Houston, Texas.

8285 El Rio Street

Suite 150

Houston, TX 77054

United States

Founded in 2002





Key Executives for Nanospectra Biosciences, Inc.

Interim Chief Executive Officer and Director
Age: 52
Acting Chief Operating Officer and Vice President of Process Development and Chemistry
Director of Clinical Research
Consultant and Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Helena Laboratories Corporation United States
Essilor of America, Inc. United States
Streamline Inc. United States
CardiArc, Ltd. United States
Dynamic Eye, Inc. United States

Recent Private Companies Transactions

Private Placement
August 22, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nanospectra Biosciences, Inc., please visit www.nanospectra.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.